Coeptis Therapeutics
COEP
COEP
43 hedge funds and large institutions have $64.2M invested in Coeptis Therapeutics in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+5
Holders Change %
+13.16%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
9
Reduced
8
Closed
5
Calls
$164K
Puts
–
Net Calls
+$164K
Net Calls Change
+$164K
Top Buyers
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$4.55M |
| 2 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$3.8M |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$3.1M |
| 4 |
EAM
Exos Asset Management
New York
|
+$1.48M |
| 5 |
LA
Linden Advisors
New York
|
+$1.31M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$5.94M |
| 2 |
D.E. Shaw & Co
New York
|
-$4.46M |
| 3 |
MSU
Mizuho Securities USA
New York
|
-$2.26M |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$1.54M |
| 5 |
CM
Cohanzick Management
Pleasantville,
New York
|
-$1.11M |
